Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome
The serratus anterior muscle is commonly involved in myofascial pain syndrome and is treated with many different injective methods. Currently, there is no definite injection point for the muscle. This study provides a suggestion for injection points for the serratus anterior muscle considering the i...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/14/4/271 |
_version_ | 1797409137994235904 |
---|---|
author | Kyu-Ho Yi Ji-Hyun Lee Hee-Jin Kim |
author_facet | Kyu-Ho Yi Ji-Hyun Lee Hee-Jin Kim |
author_sort | Kyu-Ho Yi |
collection | DOAJ |
description | The serratus anterior muscle is commonly involved in myofascial pain syndrome and is treated with many different injective methods. Currently, there is no definite injection point for the muscle. This study provides a suggestion for injection points for the serratus anterior muscle considering the intramuscular neural distribution using the whole-mount staining method. A modified Sihler method was applied to the serratus anterior muscles (15 specimens). The intramuscular arborization areas were identified in terms of the anterior (100%), middle (50%), and posterior axillary line (0%), and from the first to the ninth ribs. The intramuscular neural distribution for the serratus anterior muscle had the largest arborization patterns in the fifth to the ninth rib portion of between 50% and 70%, and the first to the fourth rib portion had between 20% and 40%. These intramuscular neural distribution-based injection sites are in relation to the external anatomical line for the frequently injected muscles to facilitate the efficiency of botulinum neurotoxin injections. Lastly, the intramuscular neural distribution of serratus anterior muscle should be considered in order to practice more accurately without the harmful side effects of trigger-point injections and botulinum neurotoxin injections. |
first_indexed | 2024-03-09T04:09:59Z |
format | Article |
id | doaj.art-c4ef8fa6e12442a990c0be9185a526e5 |
institution | Directory Open Access Journal |
issn | 2072-6651 |
language | English |
last_indexed | 2024-03-09T04:09:59Z |
publishDate | 2022-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Toxins |
spelling | doaj.art-c4ef8fa6e12442a990c0be9185a526e52023-12-03T14:01:57ZengMDPI AGToxins2072-66512022-04-0114427110.3390/toxins14040271Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain SyndromeKyu-Ho Yi0Ji-Hyun Lee1Hee-Jin Kim2COVID-19 Division, Wonju City Public Health Center, Wonju-si 26417, KoreaDivision in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, College of Dentistry, Yonsei University, Seoul 03722, KoreaDivision in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, College of Dentistry, Yonsei University, Seoul 03722, KoreaThe serratus anterior muscle is commonly involved in myofascial pain syndrome and is treated with many different injective methods. Currently, there is no definite injection point for the muscle. This study provides a suggestion for injection points for the serratus anterior muscle considering the intramuscular neural distribution using the whole-mount staining method. A modified Sihler method was applied to the serratus anterior muscles (15 specimens). The intramuscular arborization areas were identified in terms of the anterior (100%), middle (50%), and posterior axillary line (0%), and from the first to the ninth ribs. The intramuscular neural distribution for the serratus anterior muscle had the largest arborization patterns in the fifth to the ninth rib portion of between 50% and 70%, and the first to the fourth rib portion had between 20% and 40%. These intramuscular neural distribution-based injection sites are in relation to the external anatomical line for the frequently injected muscles to facilitate the efficiency of botulinum neurotoxin injections. Lastly, the intramuscular neural distribution of serratus anterior muscle should be considered in order to practice more accurately without the harmful side effects of trigger-point injections and botulinum neurotoxin injections.https://www.mdpi.com/2072-6651/14/4/271myofascial pain syndromeSihler’s methodserratus anteriortrigger point injection |
spellingShingle | Kyu-Ho Yi Ji-Hyun Lee Hee-Jin Kim Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome Toxins myofascial pain syndrome Sihler’s method serratus anterior trigger point injection |
title | Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome |
title_full | Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome |
title_fullStr | Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome |
title_full_unstemmed | Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome |
title_short | Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome |
title_sort | intramuscular neural distribution of the serratus anterior muscle regarding botulinum neurotoxin injection for treating myofascial pain syndrome |
topic | myofascial pain syndrome Sihler’s method serratus anterior trigger point injection |
url | https://www.mdpi.com/2072-6651/14/4/271 |
work_keys_str_mv | AT kyuhoyi intramuscularneuraldistributionoftheserratusanteriormuscleregardingbotulinumneurotoxininjectionfortreatingmyofascialpainsyndrome AT jihyunlee intramuscularneuraldistributionoftheserratusanteriormuscleregardingbotulinumneurotoxininjectionfortreatingmyofascialpainsyndrome AT heejinkim intramuscularneuraldistributionoftheserratusanteriormuscleregardingbotulinumneurotoxininjectionfortreatingmyofascialpainsyndrome |